Jan-Nov PE investment deal tally at USD 19.42 billion: Thornton
There were 63 private equity deals worth USD 3,019 million in November this year.
New Delhi: Private equity investments saw a significant uptrend in November with deals worth USD 3 billion, taking the year-to-date deal tally to USD 19.42 billion, says a report.
According to assurance, tax and advisory firm Grant Thornton, there were 63 private equity deals worth USD 3,019 million in November this year as against 62 such transactions worth USD 903 million in the year-ago period.
"Though private equity deal volumes remained stable, deal values surged over 3 times as compared to transaction activity during the same period last year," said Prashant Mehra- Partner at Grant Thornton India LLP.
An investment of USD 1.8 billion by Bain Capital and LIC in Axis Bank alone contributed to about 60 per cent of the total value of private equity deals in November 2017.
In terms of deal volumes, startups continue to capture the interest of the PEs contributing to about 80 per cent of the PE deal volumes, Mehra said.
During January-November, there were 687 deals worth USD 19,421 million, whereas in the same period last year the figure stood at USD 11,455 million through 899 deals.
Supported by a surge in big-ticket investments, the private equity investments recorded a significant 70 per cent increase in value as compared to YTD 2016, while volumes declined by 24 per cent.
"E-commerce, banking, real estate, startup, retail and consumer and telecom sectors brought in large deals in year- to-date 2017, contributing over 82 per cent of total values, while volumes continued to be dominated by the startup sector contributing 61 per cent of volumes," the report said.
Going forward, the pipeline for reforms in the run-up to elections in various states and government's effort to attract foreign capital in core sectors, is expected to keep the deal activity high in the coming months, Mehra said.
Sectorwise, startups, banking and insurance, e-commerce, manufacturing, pharma, healthcare and biotech will be the key sectors that are expected to see action, he added.